San Francisco Sentry Investment Group’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

San Francisco Sentry Investment Group’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-114	Closed	-$5K	–	887
2018 Q1	$5K	Hold	114	–	–	﹤0.01%	765
2017 Q4	$5K	Hold	114	–	–	﹤0.01%	765
2017 Q3	$5K	Hold	114	–	–	﹤0.01%	752
2017 Q2	$5K	Buy	+114	New	+$4.81K	﹤0.01%	612
2014 Q4	–	Sell	-114	Closed	-$6K	–	457
2014 Q3	$6K	Hold	114	–	–	﹤0.01%	525
2014 Q2	$6K	Hold	114	–	–	﹤0.01%	534
2014 Q1	$5K	Hold	114	–	–	﹤0.01%	593
2013 Q4	$5K	Hold	114	–	–	﹤0.01%	570
2013 Q3	$4K	Hold	114	–	–	﹤0.01%	571
2013 Q2	$4K	Buy	+114	New	+$3.85K	﹤0.01%	573

Other funds holding XPH

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JGGDR

JGP Global Gestao de Recursos Rio De Janeiro, Brazil $23.2M AUM 88.58% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

San Francisco Sentry Investment Group's XPH Position: Q2 2018 in Review

San Francisco Sentry Investment Group sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q2 2018, closing a stake of 114 shares — an estimated $5K sold.

San Francisco Sentry Investment Group first reported a position in XPH in Q2 2013 and held it in 10 quarters. The position peaked at $6K in Q3 2014. 70 funds tracked by Wall St. Rank hold XPH as of Q2 2018.

San Francisco Sentry Investment Group reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q2 2018 after selling out during the quarter.
San Francisco Sentry Investment Group sold 114 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2018, an estimated $5K.
San Francisco Sentry Investment Group first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2013 and held it in 10 quarters.
San Francisco Sentry Investment Group's State Street SPDR S&P Pharmaceuticals ETF position peaked at $6K in Q3 2014.
70 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2018.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2018, filed 6 Aug 2018.